BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22595486)

  • 1. Elemental micro-imaging and quantification of human substantia nigra using synchrotron radiation based x-ray fluorescence--in relation to Parkinson's disease.
    Szczerbowska-Boruchowska M; Krygowska-Wajs A; Adamek D
    J Phys Condens Matter; 2012 Jun; 24(24):244104. PubMed ID: 22595486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of electrical stimulation of vagus nerve on elemental composition of dopamine related brain structures in rats.
    Szczerbowska-Boruchowska M; Krygowska-Wajs A; Ziomber A; Thor P; Wrobel P; Bukowczan M; Zizak I
    Neurochem Int; 2012 Jul; 61(2):156-65. PubMed ID: 22561408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of cluster and discriminant analysis in the investigations of the role of trace metals in the pathogenesis of Parkinson's disease.
    Chwiej J
    J Trace Elem Med Biol; 2010 Apr; 24(2):78-88. PubMed ID: 20413064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of nerve cells from substantia nigra of patients with Parkinson's disease and amyotrophic lateral sclerosis with the use of X-ray fluorescence microscopy and multivariate methods.
    Chwiej J; Fik-Mazgaj K; Szczerbowska-Boruchowska M; Lankosz M; Ostachowicz J; Adamek D; Simionovici A; Bohic S
    Anal Chem; 2005 May; 77(9):2895-900. PubMed ID: 15859608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchrotron radiation based X-ray fluorescence shows changes in the elemental composition of the human substantia nigra in aged brains.
    Surowka AD; Wrobel P; Adamek D; Radwanska E; Szczerbowska-Boruchowska M
    Metallomics; 2015 Nov; 7(11):1522-31. PubMed ID: 26440290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomolecular investigation of human substantia nigra in Parkinson's disease by synchrotron radiation Fourier transform infrared microspectroscopy.
    Szczerbowska-Boruchowska M; Dumas P; Kastyak MZ; Chwiej J; Lankosz M; Adamek D; Krygowska-Wajs A
    Arch Biochem Biophys; 2007 Mar; 459(2):241-8. PubMed ID: 17274943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined in-situ imaging of structural organization and elemental composition of substantia nigra neurons in the elderly.
    Surowka AD; Töpperwien M; Bernhardt M; Nicolas JD; Osterhoff M; Salditt T; Adamek D; Szczerbowska-Boruchowska M
    Talanta; 2016 Dec; 161():368-376. PubMed ID: 27769419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
    Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
    Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of Cu/Zn and Fe in human serum of patients with sickle cell anemia using radiation synchrotron.
    Canellas CG; Carvalho SM; Anjos MJ; Lopes RT
    Appl Radiat Isot; 2012 Jul; 70(7):1277-80. PubMed ID: 22364784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.
    Howells DW; Porritt MJ; Wong JY; Batchelor PE; Kalnins R; Hughes AJ; Donnan GA
    Exp Neurol; 2000 Nov; 166(1):127-35. PubMed ID: 11031089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An altered histaminergic innervation of the substantia nigra in Parkinson's disease.
    Anichtchik OV; Rinne JO; Kalimo H; Panula P
    Exp Neurol; 2000 May; 163(1):20-30. PubMed ID: 10785440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study.
    Patt S; Gertz HJ; Gerhard L; Cervós-Navarro J
    Histol Histopathol; 1991 Jul; 6(3):373-80. PubMed ID: 1725760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of Cu chemical state inside single neurons from Parkinson's disease and control substantia nigra using the micro-XANES technique.
    Chwiej J; Adamek D; Szczerbowska-Boruchowska M; Krygowska-Wajs A; Bohic S; Lankosz M
    J Trace Elem Med Biol; 2008; 22(3):183-8. PubMed ID: 18755393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations of differences in iron oxidation state inside single neurons from substantia nigra of Parkinson's disease and control patients using the micro-XANES technique.
    Chwiej J; Adamek D; Szczerbowska-Boruchowska M; Krygowska-Wajs A; Wojcik S; Falkenberg G; Manka A; Lankosz M
    J Biol Inorg Chem; 2007 Feb; 12(2):204-11. PubMed ID: 17120075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The localisation and micro-mapping of copper and other trace elements in breast tumours using a synchrotron micro-XRF system.
    Farquharson MJ; Geraki K; Falkenberg G; Leek R; Harris A
    Appl Radiat Isot; 2007 Feb; 65(2):183-8. PubMed ID: 17052909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging.
    Ohtsuka C; Sasaki M; Konno K; Koide M; Kato K; Takahashi J; Takahashi S; Kudo K; Yamashita F; Terayama Y
    Neurosci Lett; 2013 Apr; 541():93-8. PubMed ID: 23428505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry.
    Biesemeier A; Eibl O; Eswara S; Audinot JN; Wirtz T; Pezzoli G; Zucca FA; Zecca L; Schraermeyer U
    J Neurochem; 2016 Jul; 138(2):339-53. PubMed ID: 27121280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nano-imaging trace elements at organelle levels in substantia nigra overexpressing α-synuclein to model Parkinson's disease.
    Lemelle L; Simionovici A; Colin P; Knott G; Bohic S; Cloetens P; Schneider BL
    Commun Biol; 2020 Jul; 3(1):364. PubMed ID: 32647232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.